1. Seifi, Samira, Nazifi, Saeed, Tabandeh, Mohammad Reza, Saeb, Mehdi. 2013. AdipoR1 and AdipoR2 gene expression are regulated by thyroid hormones in adipose tissue. In Molecular and cellular biochemistry, 377, 55-63. doi:10.1007/s11010-013-1570-5. https://pubmed.ncbi.nlm.nih.gov/23378066/
2. Peralta Romero, José de Jesús, Karam Araujo, Roberto, Burguete García, Ana Isabel, Valladares Salgado, Adán, Cruz, Miguel. 2015. ADIPOQ and ADIPOR2 gene polymorphisms: association with overweight/obesity in Mexican children. In Boletin medico del Hospital Infantil de Mexico, 72, 26-33. doi:10.1016/j.bmhimx.2015.02.002. https://pubmed.ncbi.nlm.nih.gov/29421176/
3. Zhou, Lei, Zhang, Hai-Feng, Ning, Wu, Liu, Xin, Liu, Ji-Xi. 2017. Associations of adiponectin receptor 2 (AdipoR2) gene polymorphisms and AdipoR2 protein expression levels with the risk of colorectal cancer: A case-control study. In Molecular medicine reports, 16, 3983-3993. doi:10.3892/mmr.2017.7115. https://pubmed.ncbi.nlm.nih.gov/28765899/
4. Jie, Chen, Xuan, Wang, Feng, Han-Dong, Fei, Sun, Hao, Zhang. 2021. AdipoR2 inhibits human glioblastoma cell growth through the AMPK/mTOR pathway. In European journal of medical research, 26, 28. doi:10.1186/s40001-021-00496-9. https://pubmed.ncbi.nlm.nih.gov/33752745/
5. Alzahrani, Badr, Iseli, Tristan, Ramezani-Moghadam, Mehdi, George, Jacob, Hebbard, Lionel W. 2017. The role of AdipoR1 and AdipoR2 in liver fibrosis. In Biochimica et biophysica acta. Molecular basis of disease, 1864, 700-708. doi:10.1016/j.bbadis.2017.12.012. https://pubmed.ncbi.nlm.nih.gov/29237572/
6. Chen, Yuan-Li, Ma, Yi-Cheng, Tang, Jie, Ma, Lan-Qing, Zou, Cheng-Gang. 2023. Physical exercise attenuates age-related muscle atrophy and exhibits anti-ageing effects via the adiponectin receptor 1 signalling. In Journal of cachexia, sarcopenia and muscle, 14, 1789-1801. doi:10.1002/jcsm.13257. https://pubmed.ncbi.nlm.nih.gov/37222007/
7. Siitonen, Niina, Pulkkinen, Leena, Lindström, Jaana, Tuomilehto, Jaakko, Uusitupa, Matti. 2011. Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study. In Cardiovascular diabetology, 10, 83. doi:10.1186/1475-2840-10-83. https://pubmed.ncbi.nlm.nih.gov/21943112/